home    APIs    Oncology    Dasatinib monohydrate
Dasatinibmonohydrate

Dasatinib monohydrate

Technical Data

M. Wt 506.02
Formula C22H28ClN7O3S
CAS Number 863127-77-9
Documents USFDA Approved, USDMF available, Stability Studies In Zone IVB.

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Description

Dasatinib is an oral dual BCR/ABL and Src family tyrosine kinase inhibitor approved for use in patients with chronic myelogenous leukemia (CML). The main targets of , are BCRABL, SRC, Ephrins and GFR.

Synonyms

Dasatinib, Dasatinib hydrate, dasatinib.H2O, Dasatinib (monohydrate), N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate, dasatinib-monohydrate

Disclaimer

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1)